Target intelligence / Profile preview

Mitochondrial ribosomal protein L22 pseudogene 1 (MRPL22P1)

Target
MRPL22P1
Molecular classification
Pseudogene
01

Overview

Mitochondrial ribosomal protein L22 pseudogene 1 (MRPL22P1) is a pseudogene in the human genome corresponding to the functional gene encoding mitochondrial ribosomal protein L22, which is a component of the 39S large subunit of the mitochondrial ribosome[1][2][4][5][8]. As a pseudogene, MRPL22P1 does not produce a functional protein product and is generally not considered to have a direct biological function, molecular activity, disease association, or therapeutic relevance. Pseudogenes are typically regarded as "genomic fossils"—remnants of once-functional genes—and are not considered therapeutic targets[1][2][8]. MRPL22P1 is distinct from the closely related functional genes such as MRPL22 (the actual mitochondrial ribosomal protein L22 gene) or RPL22L1 (ribosomal protein L22-like 1 gene), which are functional protein-coding genes with roles in mitochondrial protein synthesis and, in the case of RPL22L1, possible disease associations[3][6][7]. Key points: - MRPL22P1 is a non-coding, non-functional pseudogene and does not encode a receptor, enzyme, transporter, or any active protein[1][2][8]. - It has no established biological functions, disease roles, biomarkers, nor does it interact with drugs, and is not relevant as a therapeutic or biomarker target. - If you are seeking information on a potential drug target or protein with relevant functions, it is likely you meant MRPL22 (mitochondrial ribosomal protein L22) or RPL22L1 (ribosomal protein L22-like 1), not MRPL22P1 (the pseudogene)[1][2][4][7][8]. If further information is needed on the functional mitochondrial ribosomal protein L22 or its variants, please clarify or request information for MRPL22 or RPL22L1.

Other names
MRPL22P1

Beyond the preview

Go deeper on Mitochondrial ribosomal protein L22 pseudogene 1 (MRPL22P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein L22 pseudogene 1 (MRPL22P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call